{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:07:43Z","timestamp":1788480463471,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12928-020-00717-8","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T04:02:43Z","timestamp":1602129763000},"page":"452-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical factors associated with slow flow in left main coronary artery-acute coronary syndrome without cardiogenic shock"],"prefix":"10.1007","volume":"36","author":[{"given":"Kei","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3566-0394","authenticated-orcid":false,"given":"Kenichi","family":"Sakakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takunori","family":"Tsukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Seguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuke","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Momomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"717_CR1","doi-asserted-by":"publisher","first-page":"e0179756","DOI":"10.1371\/journal.pone.0179756","volume":"12","author":"Y Ye","year":"2017","unstructured":"Ye Y, Yang M, Zhang S, Zeng Y. Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound: a meta-analysis. PLoS ONE. 2017;12:e0179756.","journal-title":"PLoS ONE"},{"key":"717_CR2","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/CIRCULATIONAHA.109.906040","volume":"122","author":"N Guo","year":"2010","unstructured":"Guo N, Maehara A, Mintz GS, He Y, Xu K, Wu X, et al. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Circulation. 2010;122:1077\u201384.","journal-title":"Circulation"},{"key":"717_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ahj.2016.10.008","volume":"185","author":"C Bavishi","year":"2017","unstructured":"Bavishi C, Sardar P, Chatterjee S, Khan AR, Shah A, Ather S, et al. Intravascular ultrasound-guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: meta-analysis of randomized trials. Am Heart J. 2017;185:26\u201334.","journal-title":"Am Heart J"},{"key":"717_CR4","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.amjcard.2013.12.043","volume":"113","author":"JM Ahn","year":"2014","unstructured":"Ahn JM, Kang SJ, Yoon SH, Park HW, Kang SM, Lee JY, et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol. 2014;113:1338\u2013477.","journal-title":"Am J Cardiol"},{"key":"717_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.4244\/EIJV8I7A129","volume":"8","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Farooq V, Garcia-Garcia HM, Bourantas CV, Tian N, Dong S, et al. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients. EuroIntervention. 2012;8:855\u201365.","journal-title":"EuroIntervention"},{"key":"717_CR6","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1093\/eurheartj\/ehx512","volume":"38","author":"J Escaned","year":"2017","unstructured":"Escaned J, Collet C, Ryan N, De Maria GL, Walsh S, Sabate M, et al. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. Eur Heart J. 2017;38:3124\u201334.","journal-title":"Eur Heart J"},{"key":"717_CR7","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.jcin.2013.07.008","volume":"6","author":"G Athappan","year":"2013","unstructured":"Athappan G, Patvardhan E, Tuzcu ME, Ellis S, Whitlow P, Kapadia SR. Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting. JACC Cardiovasc Interv. 2013;6:1219\u201330.","journal-title":"JACC Cardiovasc Interv"},{"key":"717_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/jamacardio.2018.4376","volume":"4","author":"JA Valle","year":"2019","unstructured":"Valle JA, Tamez H, Abbott JD, Moussa ID, Messenger JC, Waldo SW, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis of the National Cardiovascular Data Registry Research to Practice Initiative. JAMA Cardiol. 2019;4:100\u20139.","journal-title":"JAMA Cardiol"},{"key":"717_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jjcc.2008.03.008","volume":"52","author":"K Sakakura","year":"2008","unstructured":"Sakakura K, Kubo N, Hashimoto S, Ikeda N, Funayama H, Hirahara T, et al. Determinants of in-hospital death in left main coronary artery myocardial infarction complicated by cardiogenic shock. J Cardiol. 2008;52:24\u20139.","journal-title":"J Cardiol"},{"key":"717_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1536\/ihj.54.185","volume":"54","author":"DS Sim","year":"2013","unstructured":"Sim DS, Ahn Y, Jeong MH, Kim YJ, Chae SC, Hong TJ, et al. Clinical outcome of unprotected left main coronary artery disease in patients with acute myocardial infarction. Int Heart J. 2013;54:185\u201391.","journal-title":"Int Heart J"},{"key":"717_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jcin.2011.04.004","volume":"4","author":"GB Pedrazzini","year":"2011","unstructured":"Pedrazzini GB, Radovanovic D, Vassalli G, S\u00fcrder D, Moccetti T, Eberli F, et al. Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience. JACC Cardiovasc Interv. 2011;4:627\u201333.","journal-title":"JACC Cardiovasc Interv"},{"key":"717_CR12","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1136\/hrt.2007.135822","volume":"94","author":"JH Bae","year":"2008","unstructured":"Bae JH, Kwon TG, Hyun DW, Rihal CS, Lerman A. Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study. Heart. 2008;94:1559\u2013644.","journal-title":"Heart"},{"key":"717_CR13","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1161\/01.CIR.87.6.1829","volume":"87","author":"JL Anderson","year":"1993","unstructured":"Anderson JL, Karagounis LA, Becker LC, Sorensen SG, Menlove RL. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study. Circulation. 1993;87:1829\u201339.","journal-title":"Circulation"},{"key":"717_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1253\/circj.CJ-18-0896","volume":"83","author":"H Higami","year":"2018","unstructured":"Higami H, Toyofuku M, Morimoto T, Ohya M, Fuku Y, Yamaji K, et al. Acute coronary syndrome with unprotected left main coronary artery culprit- an observation from the AOI-LMCA registry. Circ J. 2018;83:198\u2013208.","journal-title":"Circ J"},{"key":"717_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jjcc.2019.06.008","volume":"75","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto K, Sakakura K, Akashi N, Watanabe Y, Seguchi M, Taniguchi Y, et al. Association of slow flow with clinical factors in intravascular ultrasound-guided percutaneous coronary intervention for patients with left main trunk-acute myocardial infarction. J Cardiol. 2020;75:53\u20139.","journal-title":"J Cardiol"},{"key":"717_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.amjcard.2012.02.044","volume":"110","author":"U Kim","year":"2012","unstructured":"Kim U, Park JS, Kang SW, Kim YM, Park WJ, Lee SH, et al. Outcomes according to presentation with versus without cardiogenic shock in patients with left main coronary artery stenosis and acute myocardial infarction. Am J Cardiol. 2012;110:36\u20139.","journal-title":"Am J Cardiol"},{"key":"717_CR17","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1093\/eurheartj\/ehy127","volume":"39","author":"V Auffret","year":"2018","unstructured":"Auffret V, Cottin Y, Leurent G, Gilard M, Beer JC, Zabalawi A, et al. Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score. Eur Heart J. 2018;39:2090\u2013102.","journal-title":"Eur Heart J"},{"key":"717_CR18","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","volume":"28","author":"K Thygesen","year":"2007","unstructured":"Thygesen K, Alpert JS, White HD, Joint ESCAAHAWHFTFftRoMI. Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525\u201338.","journal-title":"Eur Heart J"},{"key":"717_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","volume":"80","author":"E Braunwald","year":"1989","unstructured":"Braunwald E. Unstable angina. A classification. Circulation. 1989;80:410\u20134.","journal-title":"Circulation"},{"key":"717_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jjcc.2018.02.008","volume":"72","author":"K Yamamoto","year":"2018","unstructured":"Yamamoto K, Sakakura K, Akashi N, Watanabe Y, Noguchi M, Taniguchi Y, et al. Clinical outcomes after acute myocardial infarction according to a novel stratification system linked to a rehabilitation program. J Cardiol. 2018;72:227\u201333.","journal-title":"J Cardiol"},{"key":"717_CR21","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1536\/ihj.19-126","volume":"60","author":"J Ohashi","year":"2019","unstructured":"Ohashi J, Sakakura K, Yamamoto K, Taniguchi Y, Tsukui T, Seguchi M, et al. Determinants of improvement of mid-term ejection fraction in patients with acute myocardial infarction. Int Heart J. 2019;60:1245\u201352.","journal-title":"Int Heart J"},{"key":"717_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1536\/ihj.18-067","volume":"60","author":"K Yamamoto","year":"2019","unstructured":"Yamamoto K, Sakakura K, Akashi N, Watanabe Y, Noguchi M, Taniguchi Y, et al. Comparison of clinical outcomes between the ostial versus non-ostial culprit in proximal left anterior descending artery acute myocardial infarction. Int Heart J. 2019;60:37\u201344.","journal-title":"Int Heart J"},{"key":"717_CR23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"717_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1536\/ihj.19-368","volume":"61","author":"T Kasahara","year":"2020","unstructured":"Kasahara T, Sakakura K, Yamamoto K, Taniguchi Y, Tsukui T, Seguchi M, et al. Clinical factors associated with in-hospital mortality in patients with acute myocardial infarction who required intra-aortic balloon pumping. Int Heart J. 2020;61:209\u201314.","journal-title":"Int Heart J"},{"key":"717_CR25","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jacc.2004.11.063","volume":"45","author":"SG Ellis","year":"2005","unstructured":"Ellis SG, Popma JJ, Lasala JM, Koglin JJ, Cox DA, Hermiller J, et al. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. J Am Coll Cardiol. 2005;45:1193\u2013200.","journal-title":"J Am Coll Cardiol"},{"key":"717_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jjcc.2010.01.010","volume":"56","author":"YJ Hong","year":"2010","unstructured":"Hong YJ, Jeong MH, Choi YH, Ma EH, Ko JS, Lee MG, et al. Differences in intravascular ultrasound findings in culprit lesions in infarct-related arteries between ST segment elevation myocardial infarction and non-ST segment elevation myocardial infarction. J Cardiol. 2010;56:15\u201322.","journal-title":"J Cardiol"},{"key":"717_CR27","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.jacc.2005.11.055","volume":"47","author":"C von Birgelen","year":"2006","unstructured":"von Birgelen C, Hartmann M, Mintz GS, Bose D, Eggebrecht H, Neumann T, et al. Remodeling index compared to actual vascular remodeling in atherosclerotic left main coronary arteries as assessed with long-term (> or = 12 months) serial intravascular ultrasound. J Am Coll Cardiol. 2006;47:1363\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"717_CR28","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","volume":"37","author":"GS Mintz","year":"2001","unstructured":"Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:1478\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"717_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00380-017-1050-z","volume":"33","author":"Y Watanabe","year":"2018","unstructured":"Watanabe Y, Sakakura K, Taniguchi Y, Yamamoto K, Wada H, Fujita H, et al. Determinants of slow flow following stent implantation in intravascular ultrasound-guided primary percutaneous coronary intervention. Heart Vessels. 2018;33:226\u201338.","journal-title":"Heart Vessels"},{"key":"717_CR30","doi-asserted-by":"publisher","first-page":"e0119223","DOI":"10.1371\/journal.pone.0119223","volume":"10","author":"J Li","year":"2015","unstructured":"Li J, Wu L, Tian X, Zhang J, Shi Y. Intravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction. PLoS ONE. 2015;10:e0119223.","journal-title":"PLoS ONE"},{"key":"717_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0735-1097(00)01097-4","volume":"37","author":"M Nakamura","year":"2001","unstructured":"Nakamura M, Nishikawa H, Mukai S, Setsuda M, Nakajima K, Tamada H, et al. Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol. 2001;37:63\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"717_CR32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1253\/circj.71.654","volume":"71","author":"Y Higashikuni","year":"2007","unstructured":"Higashikuni Y, Tanabe K, Yamamoto H, Aoki J, Nakazawa G, Onuma Y, et al. Relationship between coronary artery remodeling and plaque composition in culprit lesions: an intravascular ultrasound radiofrequency analysis. Circ J. 2007;71:654\u201360.","journal-title":"Circ J"},{"key":"717_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/hc0302.102610","volume":"105","author":"AP Burke","year":"2002","unstructured":"Burke AP, Kolodgie FD, Farb A, Weber D, Virmani R. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation. 2002;105:297\u2013303.","journal-title":"Circulation"},{"key":"717_CR34","doi-asserted-by":"publisher","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","volume":"47","author":"R Virmani","year":"2006","unstructured":"Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47:C13\u2013C1818.","journal-title":"J Am Coll Cardiol"},{"key":"717_CR35","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.CIR.101.6.604","volume":"101","author":"R Mehran","year":"2000","unstructured":"Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Satler LF, et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation. 2000;101:604\u201310.","journal-title":"Circulation"},{"key":"717_CR36","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.jacc.2014.02.530","volume":"63","author":"D Carrick","year":"2014","unstructured":"Carrick D, Oldroyd KG, McEntegart M, Haig C, Petrie MC, Eteiba H, et al. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). J Am Coll Cardiol. 2014;63:2088\u201398.","journal-title":"J Am Coll Cardiol"},{"key":"717_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.amjcard.2012.09.015","volume":"111","author":"RW Harrison","year":"2013","unstructured":"Harrison RW, Aggarwal A, Ou FS, Klein LW, Rumsfeld JS, Roe MT, et al. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol. 2013;111:178\u201384.","journal-title":"Am J Cardiol"},{"key":"717_CR38","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1536\/ihj.18-050","volume":"59","author":"Y Watanabe","year":"2018","unstructured":"Watanabe Y, Sakakura K, Taniguchi Y, Yamamoto K, Wada H, Momomura SI, et al. Determinants of slow flow in percutaneous coronary intervention to the culprit lesion of non-st elevation myocardial infarction. Int Heart J. 2018;59:1237\u201345.","journal-title":"Int Heart J"},{"key":"717_CR39","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jcin.2011.02.016","volume":"4","author":"A Pappalardo","year":"2011","unstructured":"Pappalardo A, Mamas MA, Imola F, Ramazzotti V, Manzoli A, Prati F, et al. Percutaneous coronary intervention of unprotected left main coronary artery disease as culprit lesion in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2011;4:618\u201326.","journal-title":"JACC Cardiovasc Interv"},{"key":"717_CR40","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jcin.2018.03.021","volume":"11","author":"K Hibi","year":"2018","unstructured":"Hibi K, Kozuma K, Sonoda S, Endo T, Tanaka H, Kyono H, et al. A randomized study of distal filter protection versus conventional treatment during percutaneous coronary intervention in patients with attenuated plaque identified by intravascular ultrasound. JACC Cardiovasc Interv. 2018;11:1545\u201355.","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-020-00717-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-020-00717-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-020-00717-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T14:37:28Z","timestamp":1633703848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-020-00717-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1007\/s12928-020-00717-8","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"assertion":[{"value":"3 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Sakakura has received speaking honoraria from Abbott Vascular, Boston Scientific, Medtronic Cardiovascular, Terumo, OrbusNeich, and NIPRO; has served as a proctor for Rotablator for Boston Scientific; and has served as a consultant for Abbott Vascular and Boston Scientific. Prof. Fujita served as a consultant for Mehergen Group Holdings, Inc. Other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}